Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) — Defensive Interval Ratio
Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has a Defensive Interval Ratio of 234 days as of March 2026. Defensive assets of CN¥2.23 Billion (cash CN¥-, short-term investments CN¥1.12 Billion, receivables CN¥1.11 Billion) cover 234 days of daily cash needs of CN¥9.53 Million/day. See Nanjing King-friend Biochemical Pharmace working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Nanjing King-friend Biochemical Pharmaceutical Co Ltd Defensive Interval Ratio (2013–2025)
This chart shows how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 234 days, meaning defensive assets of CN¥2.23 Billion can fund 234 days of operations without new revenue. See Nanjing King-friend Biochemical Pharmace net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2025)
The table below presents the year-by-year Defensive Interval Ratio for Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 603707 market cap overview.
| Year | DIR (days) | Defensive Assets (CNY) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 288 days | CN¥2.53 Billion | CN¥8.78 Million/day | CN¥- | CN¥1.32 Billion | ▼ -109 days |
| 2024 | 398 days | CN¥2.25 Billion | CN¥5.66 Million/day | CN¥- | CN¥1.06 Billion | ▲ +198 days |
| 2023 | 199 days | CN¥1.68 Billion | CN¥8.46 Million/day | CN¥- | CN¥681.99 Million | ▲ +35 days |
| 2022 | 164 days | CN¥1.22 Billion | CN¥7.41 Million/day | CN¥- | CN¥1.30 Million | ▼ -49 days |
| 2021 | 213 days | CN¥1.33 Billion | CN¥6.21 Million/day | CN¥- | CN¥259.80 Million | ▼ -13 days |
| 2020 | 226 days | CN¥1.74 Billion | CN¥7.69 Million/day | CN¥- | CN¥845.79 Million | ▲ +134 days |
| 2019 | 93 days | CN¥515.98 Million | CN¥5.57 Million/day | CN¥- | CN¥56.64 Million | ▲ +19 days |
| 2018 | 73 days | CN¥190.20 Million | CN¥2.60 Million/day | CN¥- | CN¥- | ▼ -415 days |
| 2017 | 488 days | CN¥811.85 Million | CN¥1.66 Million/day | CN¥- | CN¥520.00 Million | ▲ +315 days |
| 2016 | 174 days | CN¥82.05 Million | CN¥472.83K/day | CN¥- | CN¥- | ▼ -317 days |
| 2015 | 491 days | CN¥246.18 Million | CN¥501.59K/day | CN¥- | CN¥180.00 Million | ▲ +447 days |
| 2014 | 44 days | CN¥58.71 Million | CN¥1.33 Million/day | CN¥- | CN¥1.64 Million | ▼ -226 days |
| 2013 | 270 days | CN¥92.60 Million | CN¥342.37K/day | CN¥- | CN¥- | — |